Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
September 1, 2025
High-Dose Influenza Vaccine to Reduce Hospitalizations
Jacobo Pardo-Seco, Carmen Rodríguez-Tenreiro-Sánchez, Iago Giné-Vázquez, et al.
Circulation
|
June 7, 2025
A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial
Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Lisbet Brandi, et al.
NEJM Evidence
|
October 28, 2025
Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease
Katja Vu Bartholdy, Niklas Dyrby Johansen, Kristoffer Grundtvig Skaarup, et al.
Circulation
|
November 10, 2025
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
American Heart Journal
|
May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design Update
Mats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Lancet (London, England)
|
October 20, 2025
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
European Heart Journal
|
August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial
Manan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Journal of Preventive Cardiology
|
June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial
Caroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
The New England Journal of Medicine
|
September 1, 2025
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
JAMA
|
August 30, 2025
Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial
Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
September 1, 2025
High-Dose Influenza Vaccine to Reduce Hospitalizations
Jacobo Pardo-Seco, Carmen Rodríguez-Tenreiro-Sánchez, Iago Giné-Vázquez, et al.
Circulation
|
June 7, 2025
A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial
Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Lisbet Brandi, et al.
NEJM Evidence
|
October 28, 2025
Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease
Katja Vu Bartholdy, Niklas Dyrby Johansen, Kristoffer Grundtvig Skaarup, et al.
Circulation
|
November 10, 2025
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
American Heart Journal
|
May 31, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design Update
Mats C Højbjerg Lassen, Sine H Christensen, Niklas D Johansen, et al.
Lancet (London, England)
|
October 20, 2025
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
European Heart Journal
|
August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial
Manan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
European Journal of Preventive Cardiology
|
June 18, 2026
Effect of RSV Vaccine in Older Adults with Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial
Caroline Espersen, Mats C H Lassen, Niklas Dyrby Johansen, et al.
The New England Journal of Medicine
|
September 1, 2025
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
JAMA
|
August 30, 2025
Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial
Mats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.
Page
of 12